Items where Author is "Barzegar, M."

(2022) Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis. Multiple Sclerosis International. p. 13. ISSN 2090-2654

(2022) Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination. Clin Case Rep. e05468. ISSN 2050-0904 (Print) 2050-0904

(2022) COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Diagnostic accuracy and prognostic value of lung ultrasound in coronavirus disease (COVID-19). Polish journal of radiology. e397-e408. ISSN 1733-134X (Print) 1899-0967 (Electronic) 1733-134X (Linking)

(2022) Diagnostic accuracy and prognostic value of lung ultrasound in coronavirus disease (COVID-19). POLISH JOURNAL OF RADIOLOGY. E397-E408. ISSN 0137-7183 1899-0967 J9 - POL J RADIOL

(2022) Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in patients with multiple sclerosis. Multiple Sclerosis Journal. p. 779. ISSN 1352-4585

(2022) Hearing loss among patients with multiple sclerosis (PwMS): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis. PLOS ONE. ISSN 1932-6203 J9 - PLOS ONE

(2022) Phenolic compounds of sugar beet (<i>Beta vulgaris</i> L.): Separation method, chemical characterization, and biological properties. Food Science & Nutrition. pp. 4238-4246. ISSN 2048-7177

(2022) Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 1432-0460 (Electronic) 0179-051X (Linking)

(2022) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. pp. 21-27. ISSN 0179-051x

(2022) Prevalence of trigeminal neuralgia in multiple sclerosis: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study. Bmc Neurology. p. 10.

(2022) Sexual Dysfunction in Women with Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis. SEXUALITY AND DISABILITY. pp. 381-392. ISSN 0146-1044 1573-6717 J9 - SEX DISABIL

(2022) Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis. Psychol Health Med. pp. 1234-1244. ISSN 1354-8506

(2022) Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset. JOURNAL OF CLINICAL MEDICINE. ISSN 2077-0383 J9 - J CLIN MED

(2021) Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder. Caspian Journal of Neurological Sciences. pp. 10-16. ISSN 23834307 (ISSN)

(2021) COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review. Neurol Neuroimmunol Neuroinflamm. ISSN 2332-7812

(2021) Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis. Neurol Res Int. p. 6679197. ISSN 2090-1852 (Print) 2090-1860

(2021) Early predictors of conversion to secondary progressive multiple sclerosis. Mult Scler Relat Disord. p. 103115. ISSN 2211-0348

(2021) Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. Autoimmunity Reviews. ISSN 1568-9972

(2021) Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS). Multiple Sclerosis International. ISSN 2090-2654

(2021) Frequency of comorbidities in Neuromyelitis Optica spectrum disorder. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. Dysphagia. ISSN 0179-051x

(2021) The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica. Basic and Clinical Neuroscience. pp. 199-204. ISSN 2008-126X

(2021) The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci. pp. 1-7. ISSN 1590-1874 (Print) 1590-1874

(2016) Association of Serum Bilirubin Levels With Relapsing Remitting Multiple Sclerosis. Multiple Sclerosis Journal. p. 413. ISSN 1352-4585

(2016) Ischemic Strokes in a Young Woman With Manifestations of Multiple Sclerosis: Can Ischemic Stroke Mimic Multiple Sclerosis?. Multiple Sclerosis Journal. p. 443. ISSN 1352-4585